PT Multi Medika Internasional Tbk (MMIX) Fair Value & Analysis
Healthcare · ID · Market cap 3.6T IDR
Fair value as of: Jun 24, 2026
Analysis
PT Multi Medika Internasional Tbk (MMIX) currently trades at 705.00 IDR, while our model-based Fair Value estimate is 79.61 IDR — implying the stock looks roughly 88.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
PT Multi Medika Internasional Tbk engages in the wholesale of laboratory, pharmaceutical, and medical equipment in Indonesia. It is involved in the property leasing; wholesale of agricultural food and beverages, livestock and fishery food and beverages, non-alcoholic and non-diary beverages, textile goods, cosmetics, and other household goods and equipment; management consulting; courier agency activities; web portals; travel, conferences, and exhibitions; and meeting and event organizer services. The company was founded in 2020 and is based in Jakarta Barat, Indonesia. PT Multi Medika Internasional Tbk operates as a subsidiary of PT Multi Inti Usaha.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is PT Multi Medika Internasional Tbk (MMIX) undervalued?
What is the fair value of MMIX?
What is the quality score of MMIX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.